Literature DB >> 11199068

Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioning.

C L Cameron1, D Cella, J E Herndon, A B Kornblith, E Zuckerman, E Henderson, R B Weiss, M R Cooper, R T Silver, L Leone, G P Canellos, B A Peterson, J C Holland.   

Abstract

Persistent symptoms of nausea, distress, and vomiting triggered by reminders of cancer treatment were examined among 273 Hodgkin's disease survivors, 1 to 20 years posttreatment. Prevalence rates were high for distress and nausea but low for vomiting. Retrospective report of anticipatory symptoms during treatment was the strongest predictor of persistent symptoms, suggesting that treatment-induced symptoms are less likely to persist if conditioning does not occur initially. Time since treatment was also a significant predictor, with patients more recently treated more likely to experience persistent symptoms. Thus, an explanatory model based on classical conditioning theory successfully predicted presence of persistent symptoms. Symptoms also were associated with ongoing psychological distress, suggesting that quality of life is diminished among survivors with persistent symptoms. Recommendations for prevention and treatment of symptoms are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11199068

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  7 in total

Review 1.  State-of-the-art issues in Hodgkin's lymphoma survivorship.

Authors:  Shrujal S Baxi; Matthew J Matasar
Journal:  Curr Oncol Rep       Date:  2010-11       Impact factor: 5.075

2.  Evidence for classically conditioned fatigue responses in patients receiving chemotherapy treatment for breast cancer.

Authors:  Dana H Bovbjerg; Guy H Montgomery; George Raptis
Journal:  J Behav Med       Date:  2005-06

3.  Health-related quality of life after treatment of Hodgkin lymphoma in young adults.

Authors:  Kristin Roper; Mary E Cooley; Kathleen McDermott; Jacqueline Fawcett
Journal:  Oncol Nurs Forum       Date:  2013-07       Impact factor: 2.172

4.  Identification of adverse events that have a negative impact on quality of life in a clinical trial comparing docetaxel versus S-1 with cisplatin in lung cancer.

Authors:  Eriko Aotani; Tetsutaro Hamano; Akihiko Gemma; Masahiro Takeuchi; Toru Takebayashi; Kunihiko Kobayashi
Journal:  Int J Clin Oncol       Date:  2016-02-15       Impact factor: 3.402

5.  Determinants of health-related quality of life in long-term survivors of Hodgkin's lymphoma.

Authors:  L Wettergren; M Björkholm; U Axdorph; A Langius-Eklöf
Journal:  Qual Life Res       Date:  2004-10       Impact factor: 4.147

6.  Immunogenicity and safety of the human papillomavirus vaccine in young survivors of cancer in the USA: a single-arm, open-label, phase 2, non-inferiority trial.

Authors:  Wendy Landier; Smita Bhatia; F Lennie Wong; Jocelyn M York; Jessica S Flynn; Harrison M Henneberg; Purnima Singh; Kandice Adams; Karen Wasilewski-Masker; Brooke Cherven; Rama Jasty-Rao; Marcia Leonard; James A Connelly; Saro H Armenian; Leslie L Robison; Anna R Giuliano; Melissa M Hudson; James L Klosky
Journal:  Lancet Child Adolesc Health       Date:  2021-11-10

Review 7.  Health-related quality of life in Hodgkin lymphoma: a systematic review.

Authors:  Nadine Linendoll; Tully Saunders; Rebecca Burns; Jonathan D Nyce; Kristen B Wendell; Andrew M Evens; Susan K Parsons
Journal:  Health Qual Life Outcomes       Date:  2016-07-29       Impact factor: 3.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.